Waardenburg syndrome type 2

Waardenburg syndrome type 2 (WS2) is a rare genetic disorder belonging to the group of auditory-pigmentary syndromes known collectively as Waardenburg syndrome. Unlike Waardenburg syndrome type 1, WS2 is characterized by the absence of dystopia canthorum (widely spaced inner corners of the eyes). The condition primarily affects pigmentation and hearing. Key clinical features include sensorineural hearing loss, which is present in approximately 77% of affected individuals and is often bilateral and congenital, as well as heterochromia iridis (different colored eyes or segments of different color within one iris), premature graying of hair (poliosis), and patchy depigmentation of the skin. These features result from abnormal development and distribution of melanocytes, which are pigment-producing cells derived from the neural crest that are important not only for skin, hair, and eye color but also for normal inner ear function. Waardenburg syndrome type 2 is genetically heterogeneous. Several subtypes have been identified based on the causative gene: WS2A is caused by pathogenic variants in the MITF gene (microphthalmia-associated transcription factor) on chromosome 3p14-p13, WS2B has been mapped to chromosome 1p21-p13.3, WS2C is linked to chromosome 8p23, and WS2D is caused by mutations in the SNAI2 gene on chromosome 8q11. The MITF gene plays a central role in melanocyte development and survival, and mutations in this gene account for a significant proportion of WS2 cases, though many families remain without an identified molecular cause. There is currently no cure for Waardenburg syndrome type 2. Management is primarily supportive and focuses on early identification and treatment of hearing loss. Hearing aids or cochlear implants can be highly effective in managing sensorineural hearing loss, and early intervention with speech therapy is recommended to support language development in affected children. Dermatologic features such as skin depigmentation are generally managed with sun protection. Genetic counseling is recommended for affected individuals and their families to discuss recurrence risks and the variable expressivity of the condition.

Common questions about Waardenburg syndrome type 2